In the BioHarmony Drug Report Database
Hexocyclium
Tral (hexocyclium) is a small molecule pharmaceutical. Hexocyclium was first approved as Tral on 1982-01-01. It is known to target muscarinic acetylcholine receptor M3, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M1.
Trade Name
|
Tral |
|---|---|
Common Name
|
hexocyclium |
ChEMBL ID
|
CHEMBL1201325 |
Indication
|
|
Drug Class
|
Quaternary ammonium derivatives |
Image (chem structure or protein)